TR200103004T2 - Pirolidinkarbonilamino siklik disülfitler. - Google Patents

Pirolidinkarbonilamino siklik disülfitler.

Info

Publication number
TR200103004T2
TR200103004T2 TR2001/03004T TR200103004T TR200103004T2 TR 200103004 T2 TR200103004 T2 TR 200103004T2 TR 2001/03004 T TR2001/03004 T TR 2001/03004T TR 200103004 T TR200103004 T TR 200103004T TR 200103004 T2 TR200103004 T2 TR 200103004T2
Authority
TR
Turkey
Prior art keywords
pyrrolidincarbonylamino
compounds
cyclic disulfides
cells
cyclic
Prior art date
Application number
TR2001/03004T
Other languages
English (en)
Turkish (tr)
Inventor
Chen Li
Fotouhi Nader
Young Jackson David
Wright Tilley Jefferson
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR200103004T2 publication Critical patent/TR200103004T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
TR2001/03004T 1999-04-20 2000-04-17 Pirolidinkarbonilamino siklik disülfitler. TR200103004T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13021599P 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
TR200103004T2 true TR200103004T2 (tr) 2002-01-21

Family

ID=22443611

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03004T TR200103004T2 (tr) 1999-04-20 2000-04-17 Pirolidinkarbonilamino siklik disülfitler.

Country Status (15)

Country Link
US (1) US6265572B1 (cg-RX-API-DMAC7.html)
EP (1) EP1171452B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002542256A (cg-RX-API-DMAC7.html)
KR (1) KR100636481B1 (cg-RX-API-DMAC7.html)
CN (1) CN1167710C (cg-RX-API-DMAC7.html)
AR (1) AR023546A1 (cg-RX-API-DMAC7.html)
AT (1) ATE337331T1 (cg-RX-API-DMAC7.html)
AU (1) AU769294B2 (cg-RX-API-DMAC7.html)
BR (1) BR0009838A (cg-RX-API-DMAC7.html)
CA (1) CA2370259A1 (cg-RX-API-DMAC7.html)
DE (1) DE60030266T2 (cg-RX-API-DMAC7.html)
ES (1) ES2269141T3 (cg-RX-API-DMAC7.html)
TR (1) TR200103004T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000063234A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200108018B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
US20090043126A1 (en) * 2005-02-28 2009-02-12 Jordi Bosch I Llado Process and Methods for the Preparation of Gabapentin and Its Intermediates
AU2008219007A1 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
WO2013057096A1 (en) 2011-10-17 2013-04-25 Westfaelische Wilhelms-Universitaet Muenster Assessment of pml risk and methods based thereon
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
WO2020092401A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
ES2987796T3 (es) 2018-10-30 2024-11-18 Gilead Sciences Inc Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
DK3873884T3 (da) 2018-10-30 2025-02-17 Gilead Sciences Inc 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
AU2020329207B2 (en) 2019-08-14 2024-02-29 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds

Also Published As

Publication number Publication date
DE60030266D1 (de) 2006-10-05
EP1171452B1 (en) 2006-08-23
CN1167710C (zh) 2004-09-22
DE60030266T2 (de) 2007-07-19
US6265572B1 (en) 2001-07-24
WO2000063234A2 (en) 2000-10-26
KR20010108517A (ko) 2001-12-07
ES2269141T3 (es) 2007-04-01
KR100636481B1 (ko) 2006-10-18
CN1347419A (zh) 2002-05-01
CA2370259A1 (en) 2000-10-26
WO2000063234A3 (en) 2001-01-18
AR023546A1 (es) 2002-09-04
EP1171452A2 (en) 2002-01-16
AU769294B2 (en) 2004-01-22
AU4748200A (en) 2000-11-02
ZA200108018B (en) 2003-03-26
BR0009838A (pt) 2002-01-08
JP2002542256A (ja) 2002-12-10
ATE337331T1 (de) 2006-09-15

Similar Documents

Publication Publication Date Title
TR200000482T2 (tr) N-Aroilfenilalanin türevleri.
YU40402A (sh) 4-pirimidinil-n-acil-l-fenilalanini
CY1106628T1 (el) Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων
DE60318867D1 (de) Lösung zur nagel-verwendung
ATE375334T1 (de) Harnstoff derivate als entzündungshemmende mittel
IS7761A (is) Lyfjablanda
TR200100805T2 (tr) Tetrahidropiridoeterler
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
ATE291416T1 (de) Topische zusammensetzungen zur erhöhung der glutathion produktion
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
ID29605A (id) Konsentrat bahan aktif dengan formoterol, yang sesuai untuk penyimpanan
DE69935153D1 (de) Benzamide als kaliumkanal-inhibitoren
BR0016172A (pt) 4-piridinil-n-acil-l-fenilalaninas
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
EA200500804A1 (ru) Топические противоинфекционные композиции
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
WO2000063234A3 (en) Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists
ATE259244T1 (de) Vermeidung von gastrointestinaler schädigung
WO2006113889A3 (en) Compositions and methods for modulating interleukin-10
ATE269313T1 (de) Tryptase-inhibitoren
ATE223214T1 (de) Von milchsäure abgeleitete butyrat-prodrugs
DK1244614T3 (da) Tryptase-inhibitorer
ATE241640T1 (de) Fusidinsäure-derivate